Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy

Patient-derived tumor organoids (PDTOs) represent a significant advancement in cancer research and personalized medicine. These organoids, derived from various cancer types, have shown the ability to retain the genetic and molecular characteristics of the original tumors, allowing for the detailed s...

Full description

Saved in:
Bibliographic Details
Main Authors: Sebastien Taurin, Reem Alzahrani, Sahar Aloraibi, Layal Ashi, Rawan Alharmi, Noora Hassani
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Translational Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523324003528
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items